Contrast agents in patients on dialysis

Seminars in Dialysis

Volumn 15, Issue 4, 2002, Pages 232-236

  Dawson, Peter ^a,b  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^b MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

CHRONIC KIDNEY FAILURE; DRUG EFFECT; FEMALE; HOSPITALIZATION; HUMAN; IMAGE QUALITY; KIDNEY; KIDNEY FUNCTION TEST; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY PREVENTION; PROGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; RISK FACTOR;

CONTRAST MEDIA; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MAGNETIC RESONANCE IMAGING; MALE; PRIMARY PREVENTION; PROGNOSIS; RADIOGRAPHIC IMAGE ENHANCEMENT; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0036651410     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2002.00066.x     Document Type: Review

References (59)

1. Gries H: Chemistry of X-ray contrast agents. In: Dawson P, Cosgrove DO, Grainger RG (eds): Textbook of Contrast Media. Oxford: ISIS Medical Media, 1999, 15-22
2. Dawson P, Pitfield J: Hexabrix and the sodium problem. Br J Radiol 55:933-934, 1982
3. Dawson P, Blomley MJK: Contrast agent pharmacokinetics revisited. I. Reformulation. Acad Radiol 3:S261-S263, 1995
4. Dawson P, Blomley MJK: Contrast agent pharmacokinetics revisited. II. Computer aided analysis. Acad Radiol 3:S264-S267, 1995
5. Dawson P, Blomley MJK: Contrast media as extracellular fluid space markers adaptation of the central volume theorem. Br J Radiol 69:717-722, 1996
6. Dawson P: Pharmacokinetics of X-ray contrast agents. In: Dawson P. Cosgrove DO, Grainger RG (eds): Textbook of Contrast Media. Oxford: ISIS Medical Media, 1999, 61-74
7. Dawson P, Trewhella M, Forsling M: Vasopressin release in response to intravenously injected contrast media. Br J Radiol 63:97-100, 1990
8. Petterson G, Golman K: Contrast agents of the renal tract. In: Dawson P. Cosgrove DO, Grainger RG (eds): Textbook of Contrast Media. Oxford: ISIS Medical Media, 1999, 121-134
9. Dawson P, Howell MJ: Pharmacology of the non-ionic dimers. Br J Radiol 59:987-991, 1986.
10. Mützel W, Speck U: Pharmacokinetics and biotransformation of iohexol in the rat and the dog. Acta Radiol 362(suppl):87-92, 1980
11. Dawson P, Peters AM: Renal function and the excretion of contrast agent. Br J Radiol 69:567-569, 1996
12. Dawson P: Glomerular filtration rate determined using contrast clearance: should we all be doing it? Curr Opin Urol 28:1039-1042, 1996
13. Dawson P: Chemotoxicity of contrast media and clinical adverse effects: a review. Invest Radiol 20:52-59, 1985
14. Dawson P: Cardiovascular effects of contrast agents. Am J Cardiol 64:2E-9E, 1989
15. Wilson AJ, Sage MR: Neurotoxicity. In: Dawson P, Cosgrove DO, Grainger RG (eds): Textbook of Contrast Media. Oxford: ISIS Medical Media, 1999, 165-180
16. Dawson P, Beynon H: Contrast agents and endothelial injury. Invest Radiol 29:195-197, 1994
17. Dawson P, Harrison JG, Weisblatt E: Effect of contrast media on red cell filterability and morphology. Br J Radiol 56:707-710, 1983
18. Dawson P, Hine AL, Lui D: Contrast agent osmolality and plasma volume changes. Acta Radiol 26:753-756, 1985
19. Berns A: Nephrotoxicity of contrast media. Kidney Int 36:730-740, 1989
20. Barret BJ: Contrast nephrotoxicity. J Am Soc Nephrol 5:125-137, 1993
21. Porter GA: Contrast-associated nephropathy: presentation, pathophysiology and management. Miner Electrolyte Metab 20:230-243, 1994
22. Idee JM, Beaufils H, Bonnemain B: Iodinated contrast media-induced nephropathy: pathophysiology, clinical aspects and prevention. Fundam Clin Pharmacol 6:193-206, 1994
23. Deray G, Jacobs C: Radiocontrast nephrotoxicity: a review. Invest Radiol 30:221-225, 1995
24. Vlietstra RE, Nunn CM, Navarte J, Browne KF: Contrast nephropathy after coronary angioplasty in chronic renal insufficiency. Am Heart J 132:1049-1050, 1996
25. Rudnick MR, Berns JS, Cohen RM, Goldfarb S: Contrast media-associated nephrotoxicity. Curr Opin Nephrol Hypertens 5:127-133, 1996
26. Rudnick MR, Berns JS, Cohen RM, Goldfarb S: Contrast media-associated nephrotoxicity. Semin Nephrol 17:15-26, 1997
27. Dawson P, Freedman DB, Howell MJ, Hine AL: Contrast medium induced acute renal failure and Tamm-Horsfall proteinuria. Br J Radiol 57:577-579, 1984
28. Katzberg RW: What do we really know about contrast radiation-induced acute renal failure? Invest Radiol 24:219-220, 1989
29. Morcos SK: Contrast medium-induced nephrotoxicity. In: Dawson P, Cosgrove DO, Grainger RG (eds): Textbook of Contrast Media. Oxford: ISIS Medical Media, 1999, 135-148
30. Younathan CM, Kaude JV, Cook MD, Shaw GS, Peterson JC: Dialysis is not indicated immediately after administration on non-ionic contrast agents in patients with end-stage renal disease treated by maintenance dialysis. Am J Roentgenol 163:969-971, 1994
31. Hamani A, Petitclerc T, Jacons C, Deray G: Is dialysis indicated immediately after administration of iodinated contrast agents in patients on haemodialysis? Nephrol Dial Transplant 13:1051-1952, 1998
32. Takebayashi S, Hidai H, Chiba T: No need for immediate dialysis after administration of low-osmolality contrast medium in patients undergoing hemodialysis [letter]. Am J Kidney Dis 16:226, 2000
33. Sterner G, Frennby B, Kurkus J, Nyman U: Does post-angiographic haemodialysis reduce the risk of contrast-medium nephropathy? Scand J Urol Nephrol 34:323-326, 2000
34. Lorusso V, Taroni P, Alvino S, Spinazzi A: Pharmacokinetics and safely of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysis. Invest Radiol 36:309-316, 2001
35. Berger ED, Bader BD, Boesker J, Risler T, Erley CM: Kontrastmittelinduziertes Nierenversagen lässt sich durch Haemo-dialyse nicht verhindern. Dtsch Med Wochenschr 126(7):162-166, 2001
36. Kierdorf H, Kindler J, Winterscheid R, Hollman HJ, Vorwerk D, Speck U: Elimination of the non-ionic contrast medium iopromide in end-stage renal failure by hemodialysis. Fortschr Geb Röntgenstr Nuklearmed 128:119-123, 1989
37. Waaler A, Svaland M, Fauchald P, Jakobsen J: Elimination of iohexol, a low osmolar nonionic contrast medium, by haemodialysis in patients with chronic renal failure. Nephron 56:81-85, 1990
38. Huhn HW, Tönnis HJ, Schmidt E: Elimination von Rö ntgenkontrasmitteln durch Haemodialyse. Nieren Hochdruckkrankh 22:45-52, 1993
39. Ueda J, Furukawa T, Higashino K, et al.: Elimination of iomeprol by hemodialysis. Eur J Radiol 23:197-200, 1996
40. Furukawa T, Ueda J, Takahashi S, Higashino K, Sakaguchi K: Elimination of low-osmolality contrast-media by hemodialysis. Acta Radiol 37:966-971, 1996
41. Furukawa T, Ueda J, Takahashi S, Higashino K, Sakaguchi K, Iami T: Permeability of contrast media through haemodialysis membrane [abstract]. Eur Radiol 7(suppl):S364, 1997
42. Horiuchi K, Yoshida K, Tsuboi N, Akimoto M, Tajima H, Kumazaki T: Elimination of non-ionic contrast media by haemodialysis in patients with impaired renal function. Nippon Ika Daigaku Zasshi (J Nippon Med School) 66:305-307, 1999
43. Iwamoto M, Hiroshige K, Suda T, Ohta T, Ohtani A, Nakashima Y: Elimination of iomeprol in patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int 19:380-385, 1999
44. Johnsson K, Attman PO, Samuelsson O, Haraldsson B: Improved clearance of iohexol with longer haemodialysis despite similar Kt/V for urea. Nephrol Dial Transplant 14:2407-2412, 1999
45. Matzkies FK, Reinecke H, Tombach B, Kosch M, Hegger K, Milius M, Hohage H, Kisters K, Kerber S, Schaefer RM: Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function. Am J Nephrol 20:300-304, 2000
46. Matzkies FK, Reinecke H, Tombach B, Koeneke J, Hohage H, Kisters K, Schaefer RM: Reduced iopromide elimination in hemodialysis with euprophane membranes. Acta Radiol 41:671-673, 2000
47. Matzkies FK, Tombach B, Kisters K, Schuhmann G, Hohage H, Schaefer RM: Clearance of iopromide during haemodialysis with high- and low-flux membranes. Acta Radiol 40:220-223, 1999
48. Moon SS, Back SE, Kurkus J, Nilsson Ehle P: Hemodialysis for elimination of the non-ionic contrast medium iohexol after angiography in patients with impaired renal function. Nyphron 70:430-437, 1995
49. Sterner G, Frennby B, Mansson S, Ohlsson A, Prutz KG, Almen T: Assessing residual renal function and efficiency of hemodialysis: an application for urographic contrast media. Nephron 85:324-333, 2000
50. Dawson P, Blomley MJK: Gadolinium chelate MR contrast agents. Clin Radiol 49:439-442, 1994
51. Lundby B, Berg K, Lien H, Aamdal S: A double blind study to evaluate the tolerability of gadodiamide injection and its effects on renal function in patients undergoing cerebral magnetic resonance imaging. Br J Radiol 66:871-876, 1993
52. Haustein J, Niendorf HP, Krestin G, et al.: Renal tolerance of gadolinium-DTPA/dimeglumine in patients with chronic renal failure. Invest Radiol 27:153-156, 1992
53. Prince M R, Arnoldus C, Frisoli JK: Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imag 1:162-166, 1994
54. Bellin MF, Deray G, Assogba U, et al.: Gd-DOTA: evaluation of its renal tolerance in patients with chronic renal failure. Magn Reson Imaging 10:115-118, 1992
55. Niendorf HP, Alhassan A, Geens V, Clauss W: Safety review of gadopentate dimeglumine: extended clinical experience after more than five million applications. Invest Radiol 29:5179-5182, 1994
56. Haustein J, Schuhmann-Giampieri G: Elimination of Gd-DTPA by means of haemodialysis. Eur J Radiol 11:227-229, 1990
57. Krahe VT, Gotz R, Lackner K, et al.: Pharmakokinetik von Gadolinium-DTPA bei dialysepflichter chronische Niereninsuffizienz. Röntgenstr 156:523-526, 1992
58. Choyke P, Girton M, Vaughan E, et al.: Clearance of gadolinium chelates by haemodialysis: an in vitro study. J Magn Reson Imaging 4:470-472, 1995
59. Dorsam J, Knopp M, Schad L, et al.: Elimination of gadolinium-DTP A by peritoneal dialysis. Nephrol Dial Transplant 10:1228-1230, 1995